Arteris counsel exercises options, sells 4,000 shares
Arteris, Inc. (AIP) reported that its VP and General Counsel, Paul L. Alpern, exercised 4,000 incentive stock options for Arteris common stock on September 1, 2026 at an exercise price of $0.56 per share, receiving 4,000 common shares.
Rhea-AI Filing Summary
Arteris, Inc. (AIP) reported that its VP and General Counsel, Paul L. Alpern, exercised 4,000 incentive stock options for Arteris common stock on September 1, 2026 at an exercise price of $0.56 per share, receiving 4,000 common shares. On the same date, he sold 4,000 common shares at a weighted average price of $20.7658 per share in multiple trades between $20.61 and $21.38. Following the option exercise, he continues to hold 49,000 incentive stock options expiring on October 23, 2029. The acquisitions and sales were made pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 4,000 shares ($81K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Alpern Paul L
Role
VP and General Counsel
Sold
4,000 shs ($83K)
Approx. gross sale proceeds
$83K
Approx. exercise cost
$2K
Approx. pre-tax spread
$81K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) F3 | 4,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 4,000 | $0.56 | $2K |
| Sale | Common Stock F1, F2 | 4,000 | $20.7658 | $83K |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 49,000 contracts (Direct);
Common Stock — 70,733 shares (Direct)
Footnotes (3)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.61 to $21.38 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. Incentive stock option, 25% of the total shares vested on August 26, 2020; thereafter, 1/48th of the total shares vested monthly for 3 years, beginning on September 26, 2020.
Key Figures
Options exercised: 4,000 shares
Option exercise price: $0.56 per share
Shares sold: 4,000 shares
+4 more
7 metrics
Options exercised
4,000 shares
Incentive stock option exercise on September 1, 2026
Option exercise price
$0.56 per share
Exercise price of incentive stock option for Arteris common stock
Shares sold
4,000 shares
Arteris common stock sold on September 1, 2026
Weighted average sale price
$20.7658 per share
Common stock sales in multiple trades from $20.61 to $21.38
Options remaining after exercise
49,000 shares
Incentive stock options held directly following the reported exercise
Option expiration date
October 23, 2029
Expiration of the incentive stock option grant
Rule 10b5-1 plan adoption date
February 23, 2026
Plan governing the reported acquisitions and sales
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, Incentive Stock Option, vested monthly
4 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan that was adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
Incentive Stock Option financial
"Incentive stock option, 25% of the total shares vested"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
vested monthly financial
"thereafter, 1/48th of the total shares vested monthly for 3 years"
FAQ
What transactions did Arteris (AIP) officer Paul L. Alpern report on September 1, 2026?
He exercised 4,000 incentive stock options at $0.56 per share to acquire 4,000 Arteris common shares, and on the same day sold 4,000 common shares at a weighted average price of $20.7658 per share in multiple transactions.
Were Paul L. Alpern’s September 1, 2026 trades in AIP made under a Rule 10b5-1 plan?
Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Paul L. Alpern on February 23, 2026, indicating they followed a pre-arranged trading schedule.
What options did Paul L. Alpern exercise in this Arteris (AIP) Form 4?
He exercised 4,000 incentive stock options for Arteris common stock at an exercise price of $0.56 per share. These options are part of a grant that vests over four years and carry an expiration date of October 23, 2029.
How many Arteris (AIP) options does Paul L. Alpern hold after the reported transactions?
After the September 1, 2026 option exercise, he holds 49,000 incentive stock options for Arteris common stock directly, according to the post-transaction holdings reported in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
